Cyp7b1 repression is commonly observed during MASLD and is associated with the induction of the alternative BA synthesis pathway, leading to oxysterol accumulation, which contributes to hepatic inflammation and fibrosis [149–151]. Here, CYP7B1 is linked to metabolic dysfunction-associated steatotic liver disease.